Hpvd2
Poland
unknown
unknown
Stage
About
The company is developing a diagnostic method for detecting the two most oncogenic types of human papillomavirus (HPV) using genetic identification without requiring full genetic material isolation from throat swabs.
Explore Hpvd2's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.